explore -WSS

explore

author：leisure time 2025-08-26 23:48:25 - browse：619

Scanned cerebellum of a mouse brain, affected by Niemann-Pick Type C, shown in pink and teal — biotech coverage from STAT — The cerebellum of a mouse brain affected by Niemann-Pick Type C. Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health

About a decade ago, Tatiana Bremova-Ertl’s graduate adviser was studying an obscure, 1950s-era French vertigo drug, probing its effects on people with balance disorders, when she thought of another, very sick group of patients.

A graduate student and medical resident at the German Center for Vertigo and Balance Disorders, in Munich, Bremova-Ertl often saw patients with Niemann-Pick Type C, a rare, genetic disease that slowly kills neurons.

NPC has a range of manifestations. When symptoms appear in early childhood, it is often fatal before adulthood. When it manifests later, it can be milder. But it’s always degenerative and leads to a cluster of challenges: cognitive decline, difficulty with speech and swallowing, enlarged liver, low muscle tone, and, notably, difficulty with balance and muscle control. Researchers and a fervent group of parents were working to develop medicines, but little had yet worked.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： Researchers test human milk's ability to repair gut microbiome

knowledge

WSS

Cholera vaccine supplies dangerously low, outbreaks surging

Change Healthcare cyberattack shows risk of industry consolidation

Harvard scientists, with Google, unveil the most detailed brain map ever

Depression: FDA OKs Otsuka Pharmaceuticals digital therapeutic

Childhood vaccination ad campaign launches in the U.K.

Using force crossed my mind when examining a defiant young patient

entertainment

explore

hotspot

As demand for Covid shots wanes, Moderna seeks its next success

Scientists uncover potential path to treating deadly childhood tumor

Activists slam private health insurers over coverage restrictions

Republican states more likely to report Covid vaccine side effects

Moonlake's readout produced a cash windfall. Risks remain

Researchers test human milk's ability to repair gut microbiome

Walensky prepares to leave CDC — and Congress — behind

Study fuels hope CAR

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Gut bacteria may contribute to kidney autoimmunity, study finds

explore

Are embryos people? Reproductive medicine's future depends on the answer

Covid silver lining: Unprecedented look at human immune system

Scientific mystery highlights the blind spots in genomics databases

CDC advisory group OKs chikungunya vaccine

Children’s Hospital revives plan for pedestrian bridge

Readout Newsletter: GSK, Viking Therapeutics, mifepristone news

hotspot

focus

knowledge

hotspot